Morgan Stanley initiated coverage on Nautilus Biotechnology with a new price target

1/6/22 5:56:03 AM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Morgan Stanley initiated coverage of Nautilus Biotechnology with a rating of Equal-Weight and set a new price target of $8.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NAUT

Date	Price Target	Rating	Analyst
12/5/2024	$1.75	Neutral → Sell	Goldman
6/27/2024	$6.00	Buy	Guggenheim
6/3/2024	$3.00	Hold	Jefferies
1/6/2022	$8.00	Equal-Weight	Morgan Stanley
11/2/2021		Outperform	Cowen & Co.
8/4/2021	$10.00	Neutral	Goldman Sachs
7/13/2021	$13.00	Buy	Jefferies